Low-dose cidofovir and conversion to mTOR-based immunosuppression in polyomavirus-associated nephropathy.

Thomas MühlbacherRobert BeckSilvio NadalinNils Heyne Martina Guthoff

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

Low-dose cidofovir and conversion to mTOR-based immunosuppression allow for effective virus clearance and preservation of allograft function in a high proportion of patients with PVAN and progressive allograft dysfunction and may prolong allograft survival in these patients.

Keyphrases

low dose
end stage renal disease
high dose
kidney transplantation
cell proliferation
ejection fraction
newly diagnosed
multiple sclerosis
oxidative stress
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported
free survival